I-MAB SPONS.ADS/1 -0001 - Asset Resilience Ratio

Latest as of December 2025: 0.08%

I-MAB SPONS.ADS/1 -0001 (0VY) has an Asset Resilience Ratio of 0.08% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See I-MAB SPONS.ADS/1 -0001 (0VY) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€210.00K

≈ $245.51K USD Cash + Short-term Investments

Total Assets

€260.52 Million

≈ $304.58 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how I-MAB SPONS.ADS/1 -0001's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of I-MAB SPONS.ADS/1 -0001.

Liquid Assets Composition Over Time

This chart breaks down I-MAB SPONS.ADS/1 -0001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore I-MAB SPONS.ADS/1 -0001 (0VY) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€210.00K	0.08%
Total Liquid Assets	€210.00K	0.08%

Asset Resilience Insights

Limited Liquidity: I-MAB SPONS.ADS/1 -0001 maintains only 0.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

I-MAB SPONS.ADS/1 -0001 Industry Peers by Asset Resilience Ratio

Compare I-MAB SPONS.ADS/1 -0001's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for I-MAB SPONS.ADS/1 -0001 (2021–2025)

The table below shows the annual Asset Resilience Ratio data for I-MAB SPONS.ADS/1 -0001.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.08%	€210.00K ≈ $245.51K	€260.52 Million ≈ $304.58 Million	-49.35pp
2024-12-31	49.43%	€105.14 Million ≈ $122.91 Million	€212.68 Million ≈ $248.65 Million	+43.95pp
2023-12-31	5.48%	€20.22 Million ≈ $23.64 Million	€368.92 Million ≈ $431.31 Million	-0.30pp
2022-12-31	5.78%	€34.12 Million ≈ $39.89 Million	€590.45 Million ≈ $690.29 Million	-7.67pp
2021-12-31	13.45%	€118.16 Million ≈ $138.14 Million	€878.74 Million ≈ $1.03 Billion	--

pp = percentage points

About I-MAB SPONS.ADS/1 -0001

F:0VY Germany Biotechnology

Market Cap

$189.29 Million

€161.91 Million EUR

Market Cap Rank

#16850 Global

#1587 in Germany

Share Price

€1.40

Change (1 day)

+2.94%

52-Week Range

€1.25 - €5.60

All Time High

€70.00